Studies show that NALCN is present in various cancers, including glioblastoma, non-small cell lung cancer, pancreatic cancer, small cell lung cancer (SCLC), and tumor-derived endothelial cells [25,26,27]. Here, NALCN is linked to small cell lung carcinoma.